Boron Neutron Capture Therapy (BNCT) Market Growth Analysis, Market Dynamics, Key Players and Innovations, Outlook and F

Emergence of new centers & clinical trials globally: More hospitals and research centers, especially across Europe and Asia are acquiring capabilities and conducting trials, increasing access.

 

North America BNCT Market Analysis:

 

Report Sample includes:
- Table of Contents
- List of Tables Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/165/boron-neutron-capture-therapy-bnct

 

  • Current Market Size: Estimated at $35.73 million USD in 2023.
  • Future Growth: Expected to reach $541.54 million USD by 2030.
  • CAGR: The North American market is projected to experience a substantial CAGR of 45.98% from 2024 to 2030.

 

 

Europe BNCT Market Insights:

 

  • Current Market Size: Estimated at $22.67 million USD in 2023.
  • Future Growth: Anticipated to reach $327.32 million USD by 2030.
  • CAGR: The European market is forecasted to witness a CAGR of 44.11% during 2024-2030.

 

Asia-Pacific BNCT Market Trends:

 

  • Current Market Size: Valued at $113.25 million USD in 2023.
  • Future Growth: Expected to soar to $1,295.20 million USD by 2030.
  • CAGR: The Asia-Pacific market is set to experience a CAGR of 39.68% from 2024 to 2030.

 

Key Global BNCT Manufacturers:

 

  • Prominent Players: Neutron Therapeutics, Sumitomo Heavy Industries, International Particle Therapy Inc (IPT), RaySearch, Neuboron Medtech, TAE Life Sciences, Stella Pharma, among others.
  • Market Share: In 2023, the top five vendors collectively accounted for approximately 46.96% of the total revenue in the BNCT market.

 

This report aims to provide a comprehensive presentation of the global market for Boron Neutron Capture Therapy (BNCT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Boron Neutron Capture Therapy (BNCT).

 

The Boron Neutron Capture Therapy (BNCT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Boron Neutron Capture Therapy (BNCT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

 

The report will help the Boron Neutron Capture Therapy (BNCT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

 

  • Neutron Therapeutics
  • Sumitomo Heavy Industries
  • International Particle Therapy Inc (IPT)
  • RaySearch
  • Neuboron Medtech
  • TAE Life Sciences
  • Stella Pharma

Segment by Type

 

  • Equipment
  • Solution
  • Drug

Segment by Application

 

  • Head and Neck Cancer
  • Brain Tumor
  • Others

By Region

 

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia

 

key trends in the Boron Neutron Capture Therapy (BNCT) market:

 

Advances in boron carriers for targeted delivery: New liposomes, nanoparticles, and compounds are being developed to enable precise boron delivery to cancer cells and improve treatment efficacy.

Combination with other therapies: Combining BNCT with chemotherapy, immunotherapy, or epigenetic modulation holds promise for synergistic effects against aggressive cancers.

Expanding indications tested beyond head neck cancers: While historically used for brain tumors, trials for liver, lung, and metastatic cancers using BNCT are underway. Expanding indications can boost adoption.

Emergence of new centers clinical trials globally: More hospitals and research centers, especially across Europe and Asia are acquiring capabilities and conducting trials, increasing access.

Refinement of neutron beam generation technologies: Efforts to develop more compact, lower cost accelerator and reactor-based neutron sources can make BNCT more accessible.

 

 

 

 

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: help@intelmarketresearch.com

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports


teenablog

122 Magazine posts

Comments